Skip to search formSkip to main contentSkip to account menu

Nafronyl

Known as: 2-(Diethylamino)Ethyl Tetrahydro-Alpha-(1-Naphthylmethyl)-2-Furanpropionate, Naftidrofuryl, 2-Furanpropanoic acid, tetrahydro-alpha-(1-naphthalenylmethyl)-, 2-(diethylamino)ethyl ester 
A drug used in the management of peripheral and cerebral vascular disorders. It is claimed to enhance cellular oxidative capacity and to be a… 
National Institutes of Health

Related topics

Related topics

19 relations

Narrower (9)

ArtocoronDi-ActaneDusodrilGevatran
In BloodNafronyloxalateagonistsanalogs & derivatives

Broader (2)

Serotonin AntagonistsVasodilator Agents

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2009
Review
2009
Naftidrofuryl for intermittent claudication: meta-analysis based on individual patient data
Objective To assess the efficacy of naftidrofuryl compared with placebo in treating the symptoms of intermittent claudication… 
2001
2001
A new study demonstrates the efficacy of naftidrofuryl in the treatment of intermittent claudication. Findings of the Naftidrofuryl Clinical Ischemia Study (NCIS).
BACKGROUND The efficacy and safety of naftidrofuryl were assessed in a double blind, placebo controlled, parallel group study, in… 
Review
2000
Review
2000
Oral vasoactive medication in intermittent claudication: utile or futile?
AbstractObjective: To evaluate the role of orally administered vasoactive medication in the management of intermittent… 
1994
1994
Ginkgoextrakt EGb 761 (Tebonin®/HAES versus Naftidrofuryl (Dusodril®)HAES.* Eine randomisierte Studie zur Hörsturztherapie
: 80 patients with idiopathic sudden hearing loss existing no longer than 10 days were included in a randomised reference… 
Review
1992
Review
1992
Pharmacological Approaches to the Treatment of Intermittent Claudication
SummaryIntermittent claudication is a common condition of the elderly, occurring in 3 to 20% of individuals over the age of 65… 
Review
1990
Review
1990
Vascular Effects of Serotonin and Ischemia
Circulating 5-hydroxytryptamine originates in the gastrointestinal tract, where it overflows to the blood; part of that serotonin… 
1989
1989
A serotonin S2 antagonist, naftidrofuryl, exhibited a protective effect on ischemic neuronal damage in the gerbil
1987
1987
Effects of Cerebroprotective Agents on Cerebral Blood Flow and on Postischemic Energy Metabolism in the Rat Brain
Male Wistar rats were subjected to forebrain ischemia of 10 min duration by clamping both common carotid arteries and… 
1986
1986
Biochemical and physiological evidences for antiserotonergic properties of naftidrofuryl.
In experimental and clinical investigations, 2-(diethylamino)ethyl-tetrahydro-alpha-(1-naphthyl-methyl)-2-furanpro pionate… 
1978
1978
New approach to treatment of recent stroke.
Ninety-one patients with acute stroke participated in a double-blind, placebo-controlled trial of naftidrofuryl. Treatment was… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)